Previous 10 | Next 10 |
2023-10-09 11:37:28 ET Summary Anavex Life Sciences Corp. presented follow-on data from its Alzheimer’s disease trial. This data uses a statistical methodology that is difficult to understand. It appears that the trial, despite the claims, was not successful. ...
2023-09-18 08:16:42 ET SeqLL ( NASDAQ: SQL ) +70% . TradeUP Acquisition ( UPTD ) +11% . Tian Ruixiang Holdings ( TIRX ) +11% . Virios Therapeutics ( VIRI ) +9% terminates at-the-market sales agreement. Village Farms Inter...
2023-09-15 09:56:55 ET Summary On Thursday, Sep 14, Anavex Life Sciences released additional data from their phase 2b/3 Alzheimer's Disease trial. The company stated that (after a new post hoc analysis), the trial showed statistically significant results in one primary endpoint (A...
2023-09-14 13:02:36 ET More on Alzheimer's drug developers Cassava Sciences: Insiders Purchasing Stock, Is The Market Still Buying Simufilam? Prothena: Dunn Appointment And Bristol Opt-In Boost Validation Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Conv...
2023-09-14 07:59:22 ET More on Anavex Life Sciences Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Convincing Data Anavex: Will Be An Interesting Endgame To Watch Anavex lead candidate shows promise for Rett syndrome Anavex taps Partex to use AI fo...
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
2023-09-07 11:04:48 ET More on Lilly, Novo, etc. Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fundamentals Meet Technical Uptrends Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Se...
2023-08-18 17:02:10 ET Gainers: Anavex Life Sciences ( NASDAQ: AVXL ) +10% . Palo Alto Networks ( PANW ) +9% . Fluence Energy ( FLNC ) +5% . Stronghold Digital Mining ( SDIG ) +4% . Zscaler ( ZS ) +4% . Losers: NAPCO ...
2023-08-17 18:42:16 ET Summary Taysha Gene Therapies has made significant progress with its gene therapy, TSHA-102, for the treatment of Rett Syndrome. Positive results were observed in the first patient treated with TSHA-102, showing improvement in key efficacy measures. The ...
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...